Selected research
Market Structure
Global Food Immunomodulator Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Food Immunomodulator market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Food Immunomodulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Food Immunomodulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Food Immunomodulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Food Immunomodulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Food Immunomodulator include Danone SA, Nestle SA, Yakult Honsha Co.. Ltd., ADM, Kerry Group, Cargill Inc., IFF, DSM and Chr Hansen Holding A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Food Immunomodulator market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Food Immunomodulator and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Food Immunomodulator sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Food Immunomodulator market size, projected growth trends, production technologies, key applications, and end-use industries.
Food Immunomodulator Segment by Company
Danone SA
Nestle SA
Yakult Honsha Co.. Ltd.
ADM
Kerry Group
Cargill Inc.
IFF
DSM
Chr Hansen Holding A/S
Ingredion inc.
Sabinsa Corporation
BASF
Lonza
BioGaia
Lallemand Inc.
Tate and Lyle
Glanbia Nutritionals
Symbiotec
Amway Corporation
Bio-Thera Solutions Ltd.
Stratu
Nutrition
Food Immunomodulator Segment by Type
Powder
Tablets
Capsules
Other
Food Immunomodulator Segment by Application
Supermarket
Specialty Store
Online Sales
Other
Food Immunomodulator Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Food Immunomodulator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Food Immunomodulator and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Food Immunomodulator.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Food Immunomodulator market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Food Immunomodulator manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Food Immunomodulator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Food Immunomodulator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Tablets
- Capsules
- Other
Applications
- Supermarket
- Specialty Store
- Online Sales
- Other
Companies covered
- Danone SA
- Nestle SA
- Yakult Honsha Co.. Ltd.
- ADM
- Kerry Group
- Cargill Inc.
- IFF
- DSM
- Chr Hansen Holding A/S
- Ingredion inc.
- Sabinsa Corporation
- BASF
- Lonza
- BioGaia
- Lallemand Inc.
- Tate and Lyle
- Glanbia Nutritionals
- Symbiotec
- Amway Corporation
- Bio-Thera Solutions Ltd.
- Stratu
- Nutrition
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Food Immunomodulator Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Food Immunomodulator Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Food Immunomodulator Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Food Immunomodulator Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Food Immunomodulator Market Dynamics
- 2.1 Food Immunomodulator Industry Trends
- 2.2 Food Immunomodulator Industry Drivers
- 2.3 Food Immunomodulator Industry Opportunities and Challenges
- 2.4 Food Immunomodulator Industry Restraints
3 Food Immunomodulator Market by Manufacturers
- 3.1 Global Food Immunomodulator Revenue by Manufacturers (2021-2026)
- 3.2 Global Food Immunomodulator Sales by Manufacturers (2021-2026)
- 3.3 Global Food Immunomodulator Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Food Immunomodulator Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Food Immunomodulator Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Food Immunomodulator Manufacturers, Product Type & Application
- 3.7 Global Food Immunomodulator Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Food Immunomodulator Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Food Immunomodulator Players Market Share by Revenue in 2025
- 3.8.3 2025 Food Immunomodulator Tier 1, Tier 2, and Tier 3
4 Food Immunomodulator Market by Type
- 4.1 Food Immunomodulator Type Introduction
- 4.1.1 Powder
- 4.1.2 Tablets
- 4.1.3 Capsules
- 4.1.4 Other
- 4.2 Global Food Immunomodulator Sales by Type
- 4.2.1 Global Food Immunomodulator Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Food Immunomodulator Sales by Type (2021-2032)
- 4.2.3 Global Food Immunomodulator Sales Market Share by Type (2021-2032)
- 4.3 Global Food Immunomodulator Revenue by Type
- 4.3.1 Global Food Immunomodulator Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Food Immunomodulator Revenue by Type (2021-2032)
- 4.3.3 Global Food Immunomodulator Revenue Market Share by Type (2021-2032)
5 Food Immunomodulator Market by Application
- 5.1 Food Immunomodulator Application Introduction
- 5.1.1 Supermarket
- 5.1.2 Specialty Store
- 5.1.3 Online Sales
- 5.1.4 Other
- 5.2 Global Food Immunomodulator Sales by Application
- 5.2.1 Global Food Immunomodulator Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Food Immunomodulator Sales by Application (2021-2032)
- 5.2.3 Global Food Immunomodulator Sales Market Share by Application (2021-2032)
- 5.3 Global Food Immunomodulator Revenue by Application
- 5.3.1 Global Food Immunomodulator Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Food Immunomodulator Revenue by Application (2021-2032)
- 5.3.3 Global Food Immunomodulator Revenue Market Share by Application (2021-2032)
6 Global Food Immunomodulator Sales by Region
- 6.1 Global Food Immunomodulator Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Food Immunomodulator Sales by Region (2021-2032)
- 6.2.1 Global Food Immunomodulator Sales by Region (2021-2026)
- 6.2.2 Global Food Immunomodulator Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Food Immunomodulator Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Food Immunomodulator Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Food Immunomodulator Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Food Immunomodulator Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Food Immunomodulator Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Food Immunomodulator Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Food Immunomodulator Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Food Immunomodulator Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Food Immunomodulator Revenue by Region
- 7.1 Global Food Immunomodulator Revenue by Region
- 7.1.1 Global Food Immunomodulator Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Food Immunomodulator Revenue by Region (2021-2026)
- 7.1.3 Global Food Immunomodulator Revenue by Region (2027-2032)
- 7.1.4 Global Food Immunomodulator Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Food Immunomodulator Revenue (2021-2032)
- 7.2.2 North America Food Immunomodulator Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Food Immunomodulator Revenue (2021-2032)
- 7.3.2 Europe Food Immunomodulator Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Food Immunomodulator Revenue (2021-2032)
- 7.4.2 Asia-Pacific Food Immunomodulator Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Food Immunomodulator Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Food Immunomodulator Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Danone SA
- 8.1.1 Danone SA Company Information
- 8.1.2 Danone SA Business Overview
- 8.1.3 Danone SA Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Danone SA Food Immunomodulator Product Portfolio
- 8.1.5 Danone SA Recent Developments
- 8.2 Nestle SA
- 8.2.1 Nestle SA Company Information
- 8.2.2 Nestle SA Business Overview
- 8.2.3 Nestle SA Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Nestle SA Food Immunomodulator Product Portfolio
- 8.2.5 Nestle SA Recent Developments
- 8.3 Yakult Honsha Co.. Ltd.
- 8.3.1 Yakult Honsha Co.. Ltd. Company Information
- 8.3.2 Yakult Honsha Co.. Ltd. Business Overview
- 8.3.3 Yakult Honsha Co.. Ltd. Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Yakult Honsha Co.. Ltd. Food Immunomodulator Product Portfolio
- 8.3.5 Yakult Honsha Co.. Ltd. Recent Developments
- 8.4 ADM
- 8.4.1 ADM Company Information
- 8.4.2 ADM Business Overview
- 8.4.3 ADM Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 ADM Food Immunomodulator Product Portfolio
- 8.4.5 ADM Recent Developments
- 8.5 Kerry Group
- 8.5.1 Kerry Group Company Information
- 8.5.2 Kerry Group Business Overview
- 8.5.3 Kerry Group Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Kerry Group Food Immunomodulator Product Portfolio
- 8.5.5 Kerry Group Recent Developments
- 8.6 Cargill Inc.
- 8.6.1 Cargill Inc. Company Information
- 8.6.2 Cargill Inc. Business Overview
- 8.6.3 Cargill Inc. Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Cargill Inc. Food Immunomodulator Product Portfolio
- 8.6.5 Cargill Inc. Recent Developments
- 8.7 IFF
- 8.7.1 IFF Company Information
- 8.7.2 IFF Business Overview
- 8.7.3 IFF Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 IFF Food Immunomodulator Product Portfolio
- 8.7.5 IFF Recent Developments
- 8.8 DSM
- 8.8.1 DSM Company Information
- 8.8.2 DSM Business Overview
- 8.8.3 DSM Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 DSM Food Immunomodulator Product Portfolio
- 8.8.5 DSM Recent Developments
- 8.9 Chr Hansen Holding A/S
- 8.9.1 Chr Hansen Holding A/S Company Information
- 8.9.2 Chr Hansen Holding A/S Business Overview
- 8.9.3 Chr Hansen Holding A/S Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Chr Hansen Holding A/S Food Immunomodulator Product Portfolio
- 8.9.5 Chr Hansen Holding A/S Recent Developments
- 8.10 Ingredion inc.
- 8.10.1 Ingredion inc. Company Information
- 8.10.2 Ingredion inc. Business Overview
- 8.10.3 Ingredion inc. Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Ingredion inc. Food Immunomodulator Product Portfolio
- 8.10.5 Ingredion inc. Recent Developments
- 8.11 Sabinsa Corporation
- 8.11.1 Sabinsa Corporation Company Information
- 8.11.2 Sabinsa Corporation Business Overview
- 8.11.3 Sabinsa Corporation Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Sabinsa Corporation Food Immunomodulator Product Portfolio
- 8.11.5 Sabinsa Corporation Recent Developments
- 8.12 BASF
- 8.12.1 BASF Company Information
- 8.12.2 BASF Business Overview
- 8.12.3 BASF Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 BASF Food Immunomodulator Product Portfolio
- 8.12.5 BASF Recent Developments
- 8.13 Lonza
- 8.13.1 Lonza Company Information
- 8.13.2 Lonza Business Overview
- 8.13.3 Lonza Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Lonza Food Immunomodulator Product Portfolio
- 8.13.5 Lonza Recent Developments
- 8.14 BioGaia
- 8.14.1 BioGaia Company Information
- 8.14.2 BioGaia Business Overview
- 8.14.3 BioGaia Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 BioGaia Food Immunomodulator Product Portfolio
- 8.14.5 BioGaia Recent Developments
- 8.15 Lallemand Inc.
- 8.15.1 Lallemand Inc. Company Information
- 8.15.2 Lallemand Inc. Business Overview
- 8.15.3 Lallemand Inc. Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Lallemand Inc. Food Immunomodulator Product Portfolio
- 8.15.5 Lallemand Inc. Recent Developments
- 8.16 Tate and Lyle
- 8.16.1 Tate and Lyle Company Information
- 8.16.2 Tate and Lyle Business Overview
- 8.16.3 Tate and Lyle Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Tate and Lyle Food Immunomodulator Product Portfolio
- 8.16.5 Tate and Lyle Recent Developments
- 8.17 Glanbia Nutritionals
- 8.17.1 Glanbia Nutritionals Company Information
- 8.17.2 Glanbia Nutritionals Business Overview
- 8.17.3 Glanbia Nutritionals Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Glanbia Nutritionals Food Immunomodulator Product Portfolio
- 8.17.5 Glanbia Nutritionals Recent Developments
- 8.18 Symbiotec
- 8.18.1 Symbiotec Company Information
- 8.18.2 Symbiotec Business Overview
- 8.18.3 Symbiotec Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Symbiotec Food Immunomodulator Product Portfolio
- 8.18.5 Symbiotec Recent Developments
- 8.19 Amway Corporation
- 8.19.1 Amway Corporation Company Information
- 8.19.2 Amway Corporation Business Overview
- 8.19.3 Amway Corporation Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Amway Corporation Food Immunomodulator Product Portfolio
- 8.19.5 Amway Corporation Recent Developments
- 8.20 Bio-Thera Solutions Ltd.
- 8.20.1 Bio-Thera Solutions Ltd. Company Information
- 8.20.2 Bio-Thera Solutions Ltd. Business Overview
- 8.20.3 Bio-Thera Solutions Ltd. Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Bio-Thera Solutions Ltd. Food Immunomodulator Product Portfolio
- 8.20.5 Bio-Thera Solutions Ltd. Recent Developments
- 8.21 Stratu
- 8.21.1 Stratu Company Information
- 8.21.2 Stratu Business Overview
- 8.21.3 Stratu Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.21.4 Stratu Food Immunomodulator Product Portfolio
- 8.21.5 Stratu Recent Developments
- 8.22 Nutrition
- 8.22.1 Nutrition Company Information
- 8.22.2 Nutrition Business Overview
- 8.22.3 Nutrition Food Immunomodulator Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.22.4 Nutrition Food Immunomodulator Product Portfolio
- 8.22.5 Nutrition Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Food Immunomodulator Value Chain Analysis
- 9.1.1 Food Immunomodulator Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Food Immunomodulator Production Mode & Process
- 9.2 Food Immunomodulator Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Food Immunomodulator Distributors
- 9.2.3 Food Immunomodulator Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst